PharmacovigilanceOfficial

EMA publishes PSUSA outcome for famciclovir with 'maintenance' regulatory result

🇪🇺 EMA · Thu 19 Nov 2026

The EMA has published the single assessment of periodic safety update reports for famciclovir, concluding with a maintenance outcome for nationally authorised products.

The European Medicines Agency (EMA) has published the outcome of a periodic safety update report single assessment (PSUSA) for famciclovir, under procedure number PSUSA/00001349/202512. The documents were first published on 19 November 2026.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: EMA ↗

Article written by VigiEye from the official source (EMA). AI-assisted; check the source before acting.